The medical therapies for thoracic aortic aneurysm comprise of β-adrenergic blocking agents and angiotensin II type I receptor.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections: Old Controversies and New Opportunities
January 22, 2019
January 3, 2019
On December 20, 2018, the US Food and Drug Administration (FDA) issued a new warning against the use of fluoroquinolones in patients with connective tissue disorders and those predisposed to aortic disease.
Favorable Impact of Thoracic Endovascular Aortic Repair on Survival of Patients With Acute Uncomplicated Type B Aortic Dissection
November 26, 2018
The authors compared the early and long-term survival in 9165 patients undergoing medical therapy (95%), open repair (2%), and thoracic endovascular aortic repair (TEVAR, 2.9%) for uncomplicated acute type B dissection. One- and 5-year survivals were 84% and 60% for medical therapy, 76% and 67% for open repair, and 85% and 76% for TEVAR (log-rank, P
In Global News: Different Opioid Quantities for Different Surgeries, Testing India’s Locally-Made Heart Valve, and VATS Versus Thoracotomy
June 29, 2018
Patient Care and General Interest
February 17, 2018
A balanced comment on the occasion of the latest retrospective nonrandomised Coselli report on redo thoracoabdominal aortic aneurysms (TAAAs).
January 11, 2018
Christian Etz of the Herzzentrum Leipzig in Germany discusses spinal cord protection during thoracoabdominal aortic procedures.
August 30, 2017
Research recently published in The Annals of Thoracic Surgery retrospectively compares outcomes of treatments for dissection of the descending thoracic or thoracoabdominal aorta.
August 17, 2017
In this study of low volume surgeons (defined as performing fewer than 1 index operation annually) the authors studied outcomes in New York state for open AAA repair (OAR) and carotid endarterectomy (CEA). About 50% of surgeons performing these operations were low volume surgeons. Low volume surgeons had higher rates of operative mortality for OAR
Systemic Inflammatory Disease and Its Association With Type II Endoleak and Late Interventions After Endovascular Aneurysm Repair
February 18, 2016
The authors studied outcomes after endovascular AAA aneurysm repair (EVAR) to assess whether ongoing aortic remodeling related to systemic inflammatory disease (SID) contributes to an increased incidence of endoleak. 65% of 79 treated patients had systemic inflammatory disease. Major complication rates were increased 7-fold in the group with SID.
September 4, 2015
Long-term outcomes of endovascular (EVAR) and open repair of abdominal aortic aneurysm (AAA) were compared using a California-based dataset including more than 23,000 pts.